139 related articles for article (PubMed ID: 28186538)
1. Elevated HMGN4 expression potentiates thyroid tumorigenesis.
Kugler J; Postnikov YV; Furusawa T; Kimura S; Bustin M
Carcinogenesis; 2017 Apr; 38(4):391-401. PubMed ID: 28186538
[TBL] [Abstract][Full Text] [Related]
2. HMGN4 plays a key role in STAT3-mediated oncogenesis of triple-negative breast cancer.
Mou J; Xu X; Wang F; Kong W; Chen J; Ren J
Carcinogenesis; 2022 Oct; 43(9):874-884. PubMed ID: 35792800
[TBL] [Abstract][Full Text] [Related]
3. A ceRNA Circuitry Involving the Long Noncoding RNA Klhl14-AS, Pax8, and Bcl2 Drives Thyroid Carcinogenesis.
Credendino SC; Bellone ML; Lewin N; Amendola E; Sanges R; Basu S; Sepe R; Decaussin-Petrucci M; Tinto N; Fusco A; De Felice M; De Vita G
Cancer Res; 2019 Nov; 79(22):5746-5757. PubMed ID: 31558562
[No Abstract] [Full Text] [Related]
4. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
[TBL] [Abstract][Full Text] [Related]
5. SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency.
Herranz D; Maraver A; Cañamero M; Gómez-López G; Inglada-Pérez L; Robledo M; Castelblanco E; Matias-Guiu X; Serrano M
Oncogene; 2013 Aug; 32(34):4052-6. PubMed ID: 22986535
[TBL] [Abstract][Full Text] [Related]
6. Targeted Foxe1 Overexpression in Mouse Thyroid Causes the Development of Multinodular Goiter But Does Not Promote Carcinogenesis.
Nikitski A; Saenko V; Shimamura M; Nakashima M; Matsuse M; Suzuki K; Rogounovitch T; Bogdanova T; Shibusawa N; Yamada M; Nagayama Y; Yamashita S; Mitsutake N
Endocrinology; 2016 May; 157(5):2182-95. PubMed ID: 26982637
[TBL] [Abstract][Full Text] [Related]
7. Spatial and Temporal Expression of High-Mobility-Group Nucleosome-Binding (HMGN) Genes in Brain Areas Associated with Cognition in Individuals with Down Syndrome.
Rodríguez-Ortiz A; Montoya-Villegas JC; García-Vallejo F; Mina-Paz Y
Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946949
[TBL] [Abstract][Full Text] [Related]
8. PAX3 is a novel tumor suppressor by regulating the activities of major signaling pathways and transcription factor FOXO3a in thyroid cancer.
Liu W; Sui F; Liu J; Wang M; Tian S; Ji M; Shi B; Hou P
Oncotarget; 2016 Aug; 7(34):54744-54757. PubMed ID: 27458157
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling in undifferentiated thyroid carcinoma induced by high-dose radiation.
Bang HS; Choi MH; Kim CS; Choi SJ
J Radiat Res; 2016 Jun; 57(3):238-49. PubMed ID: 27006382
[TBL] [Abstract][Full Text] [Related]
10. PTCSC3 Is Involved in Papillary Thyroid Carcinoma Development by Modulating S100A4 Gene Expression.
Jendrzejewski J; Thomas A; Liyanarachchi S; Eiterman A; Tomsic J; He H; Radomska HS; Li W; Nagy R; Sworczak K; de la Chapelle A
J Clin Endocrinol Metab; 2015 Oct; 100(10):E1370-7. PubMed ID: 26274343
[TBL] [Abstract][Full Text] [Related]
11. HMGN4, a newly discovered nucleosome-binding protein encoded by an intronless gene.
Birger Y; Ito Y; West KL; Landsman D; Bustin M
DNA Cell Biol; 2001 May; 20(5):257-64. PubMed ID: 11410162
[TBL] [Abstract][Full Text] [Related]
12. Oncogenes, mitochondrial metabolism, and quality control in differentiated thyroid cancer.
Yi HS; Chang JY; Kim KS; Shong M
Korean J Intern Med; 2017 Sep; 32(5):780-789. PubMed ID: 28823142
[TBL] [Abstract][Full Text] [Related]
13. Gene expression in human thyrocytes and autonomous adenomas reveals suppression of negative feedbacks in tumorigenesis.
van Staveren WC; Solís DW; Delys L; Venet D; Cappello M; Andry G; Dumont JE; Libert F; Detours V; Maenhaut C
Proc Natl Acad Sci U S A; 2006 Jan; 103(2):413-8. PubMed ID: 16381821
[TBL] [Abstract][Full Text] [Related]
14. Induction and down-regulation of Sox17 and its possible roles during the course of gastrointestinal tumorigenesis.
Du YC; Oshima H; Oguma K; Kitamura T; Itadani H; Fujimura T; Piao YS; Yoshimoto T; Minamoto T; Kotani H; Taketo MM; Oshima M
Gastroenterology; 2009 Oct; 137(4):1346-57. PubMed ID: 19549530
[TBL] [Abstract][Full Text] [Related]
15. Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics.
D'Agostino M; Sponziello M; Puppin C; Celano M; Maggisano V; Baldan F; Biffoni M; Bulotta S; Durante C; Filetti S; Damante G; Russo D
J Mol Endocrinol; 2014 Apr; 52(2):121-31. PubMed ID: 24353283
[TBL] [Abstract][Full Text] [Related]
16. Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid Cancer.
Carr FE; Tai PW; Barnum MS; Gillis NE; Evans KG; Taber TH; White JH; Tomczak JA; Jaworski DM; Zaidi SK; Lian JB; Stein JL; Stein GS
Endocrinology; 2016 Aug; 157(8):3278-92. PubMed ID: 27253998
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
[TBL] [Abstract][Full Text] [Related]
18. The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium.
Russell JP; Powell DJ; Cunnane M; Greco A; Portella G; Santoro M; Fusco A; Rothstein JL
Oncogene; 2000 Nov; 19(50):5729-35. PubMed ID: 11126359
[TBL] [Abstract][Full Text] [Related]
19. Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells.
Tseng LM; Huang PI; Chen YR; Chen YC; Chou YC; Chen YW; Chang YL; Hsu HS; Lan YT; Chen KH; Chi CW; Chiou SH; Yang DM; Lee CH
J Pharmacol Exp Ther; 2012 May; 341(2):410-23. PubMed ID: 22328572
[TBL] [Abstract][Full Text] [Related]
20. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
